Boston Biopharma
Boston Biopharma: US-based pioneers in specialty medications, focusing on R&D, licensing, and global distribution.
Founded
2012Boston Biopharma: US-based pioneers in specialty medications, focusing on R&D, licensing, and global distribution.
Founded in the United States, Boston Biopharma is dedicated to providing high-quality specialty medications globally, with a particular focus on emerging markets. The company's core mission is to enhance patient care through pioneering research and development, as well as through licensing, manufacturing, and commercializing advanced pharmaceutical products. Their product portfolio includes cancer medications, inhalation anesthesia agents, and treatments for cystic fibrosis, addressing critical needs in the healthcare sector.
Boston Biopharma has garnered attention for its impactful contributions to global health, particularly in underserved regions. The company collaborates with leading researchers and healthcare professionals to ensure the efficacy and safety of its products. Notable achievements include the successful distribution of US-made inhalation anesthetic agents and innovative cystic fibrosis treatments. Through these efforts, Boston Biopharma has significantly improved access to essential medications, thereby enhancing the quality of life for countless patients worldwide.
Companies similar to Boston Biopharma include Goldfinch Bio, Anthera Pharmaceuticals, Amphastar Pharmaceuticals and Epirus Biopharmaceuticals.
Boston Biopharma was founded in 2012.
Boston Biopharma's headquarters is located in Alpharetta, GA, US.
Boston Biopharma's most recent funding round was for $1.5M (USD) in April 2021.
As of Apr 29, 2021, Boston Biopharma has disclosed funding of $1.5M (USD). Undisclosed round amounts are excluded.
Boston Biopharma has 12 employees as of Feb 5, 2024.
Epirus Biopharmaceuticals
